Kimberly-Clark Corp. operates in 3 segments: Personal Care; Consumer Tissue; and K-C Professional.
Paying user area
Try for free
Kimberly-Clark Corp. pages available for free this week:
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Kimberly-Clark Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Segment Profit Margin
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Personal Care | |||||
Consumer Tissue | |||||
K-C Professional |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
- Personal Care Segment Profit Margin
- The Personal Care segment profit margin showed moderate fluctuations over the five-year period. Beginning at 20.53% in 2016, it experienced a slight increase to 21.01% in 2017, followed by a mild decline to 20.28% in 2018. In 2019, the margin improved again to 20.9%, before a small decrease to 20.7% in 2020. Overall, the profit margin remained relatively stable, exhibiting minor variations around the 20% level.
- Consumer Tissue Segment Profit Margin
- The Consumer Tissue segment demonstrated more pronounced variability in profit margins. Starting at 18.72% in 2016, there was a downward trend through 2017 and 2018, reaching a low of 14.55%. Subsequently, the margin recovered to 16.8% in 2019 and increased substantially to 21.55% in 2020. This indicates a significant rebound in profitability in the final year, possibly reflecting improved cost management or favorable market conditions.
- K-C Professional Segment Profit Margin
- The K-C Professional segment exhibited moderate fluctuations with an overall slightly declining trend. The margin began at 19.14% in 2016 and increased to 19.73% in 2017. It then decreased to 18.75% in 2018 but saw a recovery to 19.96% in 2019. However, in 2020, the margin declined notably to 17.49%, representing the lowest point in the period analyzed. This decline may indicate challenges faced by the segment in the most recent year.
- Summary
- Across the three segments, profit margins have shown varied patterns. The Personal Care segment maintained relatively stable margins near the 20% mark. The Consumer Tissue segment experienced significant volatility, with a sharp decline followed by a strong recovery to its highest margin in the period. The K-C Professional segment showed minor instability but ended with a marked decrease in 2020. These trends suggest differing operational or market dynamics affecting each segment over the analyzed period.
Segment Profit Margin: Personal Care
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Operating profit | |||||
Net sales | |||||
Segment Profitability Ratio | |||||
Segment profit margin1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment profit margin = 100 × Operating profit ÷ Net sales
= 100 × ÷ =
The analysis of the financial performance over the five-year period reveals several notable trends in the Personal Care segment.
- Operating Profit
- The operating profit showed a generally positive trajectory, beginning at 1857 million US dollars in 2016 and reaching a peak of 1933 million US dollars in 2020. There was a slight dip observed in 2018, where operating profit decreased to 1833 million US dollars from 1907 million in 2017, but the figure recovered in the following years.
- Net Sales
- Net sales appeared relatively stable with a marginal upward trend. Starting at 9046 million US dollars in 2016, net sales experienced minor fluctuations but gradually increased to 9339 million US dollars by 2020. The variation over the years was minimal, indicating consistent demand or pricing strategies in this segment.
- Segment Profit Margin
- The segment profit margin demonstrated some variation, with minor decreases and increases over time. It began at 20.53% in 2016, peaked at 21.01% in 2017, and then decreased slightly to 20.28% in 2018. In the final two years, margins were relatively stable, standing at 20.9% in 2019 and slightly decreasing to 20.7% in 2020. This pattern suggests that while the company maintained relatively steady profitability levels, margins were subject to some fluctuations possibly due to cost changes or pricing pressures.
Overall, the data indicates stable and slightly improving profitability and sales in the Personal Care segment, with operating profit and net sales showing resilience and a modest growth trend. The profit margin, while fluctuating, remained around the 20-21% range, reflecting consistent operational efficiency in the segment.
Segment Profit Margin: Consumer Tissue
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Operating profit | |||||
Net sales | |||||
Segment Profitability Ratio | |||||
Segment profit margin1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment profit margin = 100 × Operating profit ÷ Net sales
= 100 × ÷ =
- Operating Profit
- The operating profit exhibited a fluctuating trend over the five-year period. Starting at $1,117 million in 2016, it declined to $1,034 million in 2017 and further decreased to $875 million in 2018. However, a recovery was observed in 2019 with an increase to $1,007 million, followed by a significant rise to $1,448 million in 2020, marking the highest value within the timeframe.
- Net Sales
- Net sales remained relatively stable from 2016 to 2019, with minor variations around the $6 billion mark. Specifically, net sales started at $5,967 million in 2016, slightly decreased to $5,932 million in 2017, increased to $6,015 million in 2018, and marginally dropped to $5,993 million in 2019. In 2020, net sales saw a notable increase to $6,718 million, indicating an upward shift in revenue generation.
- Segment Profit Margin
- The segment profit margin showed a decreasing trend initially, moving from 18.72% in 2016 down to 14.55% in 2018. This was followed by a recovery phase with margins increasing to 16.8% in 2019 and further improving significantly to 21.55% in 2020. The margin in 2020 represents the highest profitability ratio within the analyzed periods, suggesting improvement in operational efficiency or pricing power.
Segment Profit Margin: K-C Professional
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Operating profit | |||||
Net sales | |||||
Segment Profitability Ratio | |||||
Segment profit margin1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment profit margin = 100 × Operating profit ÷ Net sales
= 100 × ÷ =
- Operating Profit
- The operating profit showed a modest increase from 603 million USD in 2016 to a peak of 657 million USD in 2019. However, there was a noticeable decline in 2020, dropping to 528 million USD. This represents a significant reduction in profitability during the last recorded period.
- Net Sales
- Net sales exhibited a general upward trend initially, rising from 3,150 million USD in 2016 to a high of 3,382 million USD in 2018. After that, sales declined slightly to 3,292 million USD in 2019 and more sharply to 3,019 million USD in 2020, indicating a contraction in sales volume or pricing.
- Segment Profit Margin
- The segment profit margin fluctuated over the periods. It increased from 19.14% in 2016 to 19.96% in 2019, showing improved efficiency or profitability relative to sales. However, in 2020, the margin dropped significantly to 17.49%, reflecting reduced profitability on the same sales base.
- Overall Analysis
- Over the five-year span, the segment experienced growth in both sales and operating profit until 2019, followed by declines in 2020. The decrease in both operating profit and segment margin in 2020 suggests increased cost pressures, lower sales, or a combination of both, which negatively impacted profitability. The data implies challenges in maintaining sales volumes and controlling costs to sustain profitability during the final year.
Segment Return on Assets (Segment ROA)
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Personal Care | |||||
Consumer Tissue | |||||
K-C Professional |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
The return on assets (ROA) percentages for the three reportable segments present distinct trends over the five-year period analyzed. Overall, the data indicates shifting performance dynamics within the segments, marked by some volatility and notable changes in the most recent year.
- Personal Care
- The Personal Care segment demonstrates a generally declining trend in ROA from 2016 to 2020. Starting from a relatively high 30.24% in 2016, the ROA declines modestly through 2017 to 2019, with values of 28.93%, 29.53%, and 28.72%, respectively. However, the decline accelerates in 2020, dropping sharply to 22.78%. This downward trajectory suggests challenges affecting asset efficiency in this segment, particularly pronounced in the latest year under review.
- Consumer Tissue
- The Consumer Tissue segment exhibits a more variable pattern. The ROA decreases significantly from 23.46% in 2016 to a low of 18.47% in 2018. However, this trend reverses in 2019 and 2020, with ROA increasing to 20.33% and then surging to 27.7%. The marked improvement in 2020 contrasts with prior years, indicating a recovery or operational improvement that has positively impacted asset utilization.
- K-C Professional
- The K-C Professional segment shows a relatively stable and slightly declining ROA over the initial years. Beginning at 28.03% in 2016, the ROA remains around the high 27% range through 2017 and 2018, slightly dropping to 26.9% in 2019. In 2020, however, the ROA experiences a pronounced decline to 20.7%, paralleling the sharp decrease seen in the Personal Care segment during the same year.
In summary, the data reflects that both the Personal Care and K-C Professional segments experienced a significant reduction in ROA in 2020 after a period of relative stability or slow decline. Conversely, the Consumer Tissue segment, after facing a decrease until 2018, recovered strongly in 2019 and 2020. This divergence suggests that external or segment-specific factors impacted asset returns differently across the business lines, particularly in the latest fiscal year.
Segment ROA: Personal Care
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Operating profit | |||||
Assets | |||||
Segment Profitability Ratio | |||||
Segment ROA1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment ROA = 100 × Operating profit ÷ Assets
= 100 × ÷ =
- Operating Profit
- The operating profit displayed a generally stable pattern with minor fluctuations. It rose slightly from 1857 million USD in 2016 to a peak of 1907 million USD in 2017, followed by a decline to 1833 million USD in 2018. Subsequently, it recovered somewhat, reaching 1904 million USD in 2019 and then increasing further to 1933 million USD in 2020. Overall, the operating profit maintained a relatively consistent range over the five-year period with a modest upward trend by 2020.
- Assets
- Assets demonstrated an overall increasing trend, beginning at 6141 million USD in 2016 and reaching 8486 million USD in 2020. There were some fluctuations through the years, with assets rising to 6592 million USD in 2017, declining slightly to 6208 million USD in 2018, increasing again to 6630 million USD in 2019, and then showing a significant jump in 2020. The substantial increase in 2020 suggests a notable expansion or investment occurred in that year.
- Segment Return on Assets (ROA)
- The segment ROA decreased gradually over the period, starting from 30.24% in 2016 and declining to 22.78% in 2020. There was a consistent downward trajectory with minor variations, dropping to 28.93% in 2017, slightly bouncing back to 29.53% in 2018, before continuing its decline to 28.72% in 2019 and then falling more sharply by 2020. This indicates that despite increasing assets, the segment's efficiency in generating operating profit from its asset base diminished over time.
- Summary
- While operating profit remained relatively stable with a slight upward trend, and assets increased significantly, the segment ROA exhibited a declining trend, signaling reduced asset utilization efficiency. The marked asset growth in 2020 did not correspond with a proportional increase in operating profit, contributing to the drop in ROA. This suggests that asset growth outpaced profit generation, which may warrant further examination of asset deployment or segment operational efficiency.
Segment ROA: Consumer Tissue
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Operating profit | |||||
Assets | |||||
Segment Profitability Ratio | |||||
Segment ROA1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment ROA = 100 × Operating profit ÷ Assets
= 100 × ÷ =
- Operating Profit
- The operating profit exhibited a fluctuating trend over the period. It started at $1,117 million in 2016, then decreased to $1,034 million in 2017 followed by a further decline to $875 million in 2018. However, there was a recovery starting in 2019 with operating profit rising to $1,007 million and a significant increase reaching $1,448 million in 2020. This indicates a period of initial contraction followed by a strong growth phase in the latter years.
- Assets
- Assets showed modest variation during the timeframe. The value was $4,761 million in 2016, increased slightly to $5,007 million in 2017, then decreased to $4,738 million in 2018. This was followed by a gradual increase to $4,954 million in 2019 and a further increase to $5,227 million in 2020. Overall, the asset base remained relatively stable with slight growth toward the end of the period.
- Segment Return on Assets (ROA)
- The segment ROA presented a pattern similar to operating profits but with more significant changes. It declined from 23.46% in 2016 to 20.65% in 2017 and further dropped to 18.47% in 2018, reflecting decreased efficiency in asset utilization. Then, an improvement was observed with ROA increasing to 20.33% in 2019, followed by a substantial rise to 27.7% in 2020. This improvement in 2020 signifies enhanced profitability relative to asset levels, aligning with the increase in operating profit.
- Overall Analysis
- The segment demonstrated volatility in profitability and asset efficiency from 2016 through 2018, with both operating profit and ROA declining. Starting in 2019, there was a turnaround marked by rising operating profit and improved ROA, culminating in strong performance in 2020. Asset levels remained relatively steady with a slight upward trend, supporting this growth phase. The marked increase in ROA and operating profit in 2020 suggests successful strategic or operational initiatives improving profitability and asset utilization in that year.
Segment ROA: K-C Professional
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Operating profit | |||||
Assets | |||||
Segment Profitability Ratio | |||||
Segment ROA1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment ROA = 100 × Operating profit ÷ Assets
= 100 × ÷ =
- Operating Profit
- The operating profit displayed a generally stable trend from 2016 to 2019, increasing modestly from 603 million US dollars in 2016 to 657 million US dollars in 2019. However, in 2020, there was a noticeable decline to 528 million US dollars, representing a significant reduction compared to the previous year.
- Assets
- Assets showed a consistent upward trend throughout the entire period under review. The asset base increased steadily from 2151 million US dollars in 2016 to 2551 million US dollars by the end of 2020, indicating ongoing growth in the segment's resources.
- Segment Return on Assets (ROA)
- The segment ROA remained relatively stable and high between 2016 and 2019, fluctuating slightly between 26.9% and 28.1%. In 2020, there was a marked decline to 20.7%, suggesting a reduction in the segment's efficiency in generating operating profit from its asset base during that year.
- Overall Analysis
- The data indicates that while asset growth was steady over the five-year period, operating profitability and return on assets experienced a downturn in 2020. This divergence suggests either operational challenges or external factors impacting profitability despite continued investment and asset accumulation. The substantial decrease in ROA highlights a less efficient use of assets in generating operating profit in the latest year examined.
Segment Asset Turnover
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Personal Care | |||||
Consumer Tissue | |||||
K-C Professional |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
- Personal Care Segment Asset Turnover
- The asset turnover ratio exhibited a generally declining trend over the five-year period. It started at 1.47 in 2016, decreased to 1.38 in 2017, rebounded slightly to 1.46 in 2018, then declined again to 1.37 in 2019, and ended lower at 1.10 in 2020. This pattern suggests a reduction in efficiency in utilizing assets to generate revenue, particularly notable in the sharp decline observed in 2020.
- Consumer Tissue Segment Asset Turnover
- This segment showed moderate fluctuations but maintained relatively stable asset turnover ratios. Beginning at 1.25 in 2016, the ratio decreased slightly to 1.18 in 2017, then increased to 1.27 in 2018, followed by a small drop to 1.21 in 2019, and finally increased again to 1.29 in 2020. The slight recovery in 2020 indicates improved asset utilization efficiency in the latest year measured.
- K-C Professional Segment Asset Turnover
- The K-C Professional segment demonstrated a gradual downward trend in asset turnover ratio. Starting at 1.46 in 2016, the ratio slightly decreased to 1.42 in 2017, increased to 1.48 in 2018, then declined more noticeably to 1.35 in 2019 and further to 1.18 in 2020. This decline points to reduced operational efficiency in asset use over time, with a more pronounced drop in the most recent two years.
- Overall Insights
- Across all reviewed segments, asset turnover ratios generally declined or exhibited modest fluctuations, with 2020 reflecting the most significant decreases in most cases. The Personal Care and K-C Professional segments both experienced notable reductions in asset turnover in 2020, suggesting challenges in generating revenue from existing assets during that year. In contrast, the Consumer Tissue segment maintained a relatively stable and slightly improving efficiency throughout the period.
Segment Asset Turnover: Personal Care
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Net sales | |||||
Assets | |||||
Segment Activity Ratio | |||||
Segment asset turnover1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment asset turnover = Net sales ÷ Assets
= ÷ =
- Net Sales
- The net sales in the personal care segment exhibited relative stability over the period from 2016 to 2020, with values fluctuating narrowly between approximately 9,000 million and 9,340 million US dollars. Notably, there was a slight increase from 9,046 million in 2016 to 9,339 million in 2020, indicating a modest upward trend in revenue generation within this segment.
- Assets
- Total assets allocated to the personal care segment showed a general upward trend over the five-year period. Starting at 6,141 million US dollars in 2016, assets grew steadily with minor fluctuations, reaching a significant increase to 8,486 million in 2020. This represents overall growth in asset investment or accumulation within the segment.
- Segment Asset Turnover
- The segment asset turnover ratio, which measures the efficiency of asset utilization in generating sales, showed a declining trend throughout the period. It decreased from 1.47 in 2016 to 1.1 in 2020, suggesting that despite the growth in assets, the segment's ability to generate sales from these assets has diminished. This decline points to reduced operational efficiency or possibly the impact of asset base expansion outpacing sales growth.
- Summary of Trends
- Overall, the personal care segment demonstrated steady net sales alongside increasing assets, which led to a decrease in asset turnover ratio. The data indicate that while the segment expanded its asset base, the growth in sales did not keep pace proportionally, resulting in lower efficiency in asset utilization over the observed period.
Segment Asset Turnover: Consumer Tissue
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Net sales | |||||
Assets | |||||
Segment Activity Ratio | |||||
Segment asset turnover1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment asset turnover = Net sales ÷ Assets
= ÷ =
- Net Sales
- Net sales for the segment show a relatively stable trend from 2016 to 2019, fluctuating slightly around the 5900 to 6000 million US dollar range. A notable increase occurs in 2020, with net sales rising to 6718 million US dollars, representing a significant growth compared to previous years.
- Assets
- The asset base for the segment demonstrates moderate fluctuations over the period. Assets increased from 4761 million US dollars in 2016 to 5007 million in 2017, then decreased to 4738 million in 2018. From 2018 onwards, assets show a gradual upward movement, reaching 5227 million by the end of 2020.
- Segment Asset Turnover
- The asset turnover ratio, which measures the efficiency of assets in generating sales, varies slightly but remains within a narrow band. It starts at 1.25 in 2016, dips to 1.18 in 2017, then rises to 1.27 in 2018. In 2019, it decreases to 1.21 before recovering to 1.29 in 2020, indicating an improvement in asset utilization during the last recorded period.
- Overall Analysis
- The data reveals that despite some fluctuations in asset levels and asset turnover efficiency, net sales remained relatively consistent until 2020. The sharp increase in net sales in 2020, coupled with the highest recorded asset turnover ratio, suggests enhanced operational performance or increased market demand during that year. The incremental growth in assets in the latter years supports the segment's capacity to generate higher sales.
Segment Asset Turnover: K-C Professional
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Net sales | |||||
Assets | |||||
Segment Activity Ratio | |||||
Segment asset turnover1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment asset turnover = Net sales ÷ Assets
= ÷ =
- Net Sales
- Net sales exhibited an initial upward trend from 2016 to 2018, increasing from 3,150 million US dollars to 3,382 million US dollars. However, after peaking in 2018, net sales experienced a decline over the next two years, decreasing to 3,292 million US dollars by the end of 2019 and further dropping to 3,019 million US dollars in 2020. This suggests a reversal in sales growth during the latter part of the period analyzed.
- Assets
- Assets showed a consistent growth pattern throughout the entire period. Starting at 2,151 million US dollars in 2016, assets rose steadily each year, reaching 2,551 million US dollars by the end of 2020. This trend indicates a continued investment or accumulation of resources within the segment over these years.
- Segment Asset Turnover
- The segment asset turnover ratio declined over the period under review. Beginning at 1.46 in 2016, the ratio showed slight fluctuation but an overall downward trajectory, falling to 1.42 in 2017, a brief rise to 1.48 in 2018, followed by more notable declines to 1.35 in 2019 and reaching its lowest point at 1.18 in 2020. This decreasing ratio suggests reduced efficiency in generating sales from assets over time.
Segment Capital Expenditures to Depreciation
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Personal Care | |||||
Consumer Tissue | |||||
K-C Professional |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
The analysis of the segment capital expenditures to depreciation ratios over the five-year period reveals varied trends across the three reportable segments.
- Personal Care
- The ratio exhibits fluctuations, starting at 1.38 in 2016 and experiencing a decline to 0.97 by 2018. Subsequently, it increases steadily, reaching a peak of 1.78 in 2020. This pattern indicates an initial reduction in capital expenditure relative to depreciation, followed by a strengthened investment posture in the latter years.
- Consumer Tissue
- This segment shows moderate variability with ratios oscillating between 0.89 and 1.31. The ratio increases from 0.89 in 2016 to a local peak of 1.31 in 2019, then slightly decreases to 1.17 in 2020. Overall, the segment maintains a ratio close to unity, suggesting that capital expenditures and depreciation were largely balanced with some modest investment surges.
- K-C Professional
- The ratio demonstrates a marked upward trend, remaining constant at 0.82 for the first two years before sharply increasing to 1.3 in 2018, then climbing further to 1.84 by 2020. This consistent rise signifies an increasing focus on capital investments relative to asset depreciation, highlighting a potential expansion or upgrade of capacity within this segment.
Overall, the data suggests that while the Personal Care segment experienced fluctuations before intensifying capital investments, the K-C Professional segment shows a clear, sustained increase in investment relative to depreciation. The Consumer Tissue segment’s ratio remains relatively stable, with moderate growth and minor declines, implying a more conservative or balanced investment approach during the reviewed period.
Segment Capital Expenditures to Depreciation: Personal Care
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Capital spending | |||||
Depreciation and amortization | |||||
Segment Financial Ratio | |||||
Segment capital expenditures to depreciation1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment capital expenditures to depreciation = Capital spending ÷ Depreciation and amortization
= ÷ =
- Capital Spending
- Capital spending exhibited an overall increasing trend over the analyzed five-year period. Starting at US$421 million in 2016, it slightly decreased to US$405 million in 2017, followed by a modest increase to US$415 million in 2018. A more substantial rise occurred in 2019, reaching US$518 million, continuing to grow significantly to US$616 million by 2020.
- Depreciation and Amortization
- The depreciation and amortization expense showed growth from 2016 to 2019, starting at US$305 million in 2016, increasing steadily to US$324 million in 2017, and reaching a peak of US$430 million in 2019. However, a notable decline occurred in 2020, with the expense decreasing to US$347 million.
- Segment Capital Expenditures to Depreciation Ratio
- This ratio fluctuated throughout the period, beginning at 1.38 in 2016, then decreasing to 1.25 in 2017 and dropping below 1.0 to 0.97 in 2018, indicating capital expenditures were slightly less than depreciation that year. The ratio improved to 1.20 in 2019, and substantially increased to 1.78 in 2020, reflecting a stronger reinvestment in capital assets relative to depreciation expense during the latest year.
Segment Capital Expenditures to Depreciation: Consumer Tissue
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Capital spending | |||||
Depreciation and amortization | |||||
Segment Financial Ratio | |||||
Segment capital expenditures to depreciation1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment capital expenditures to depreciation = Capital spending ÷ Depreciation and amortization
= ÷ =
The annual data for the Consumer Tissue segment reveals several noteworthy trends over the five-year period from 2016 to 2020. There is a general upward movement in capital spending, with values increasing from $250 million in 2016 to a peak of $489 million in 2019, followed by a decline to $391 million in 2020. This indicates a significant investment surge in 2019, which then moderated the following year.
Depreciation and amortization expenses show a consistent upward trajectory from $280 million in 2016 to $372 million in 2019, before decreasing to $334 million in 2020. This pattern suggests increasing asset bases or capitalized costs over the years until 2019, with a slight reduction in amortization or asset base changes occurring in 2020.
The ratio of segment capital expenditures to depreciation fluctuates over the period, ranging from a low of 0.89 in 2016 to a high of 1.31 in 2019. This ratio generally stays near or above 1.0 starting in 2017, indicating that capital investments frequently met or exceeded the annual depreciation expense, implying growth or renewal in asset investments. The highest ratio in 2019 corresponds with the peak capital spending, after which the ratio declines to 1.17 in 2020, still above the earlier years but suggesting a reduced rate of capital reinvestment relative to asset depreciation compared to 2019.
Overall, the data suggests a phase of increased capital investment and asset renewal culminating in 2019, followed by a moderated investment approach in 2020. Depreciation trends align broadly with investment activity, reflecting asset base expansions and subsequent maintenance levels across the timeframe analyzed.
Segment Capital Expenditures to Depreciation: K-C Professional
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Capital spending | |||||
Depreciation and amortization | |||||
Segment Financial Ratio | |||||
Segment capital expenditures to depreciation1 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
1 2020 Calculation
Segment capital expenditures to depreciation = Capital spending ÷ Depreciation and amortization
= ÷ =
- Capital Spending Trend
- Capital spending has demonstrated a consistent upward trajectory from 2016 to 2020, starting at $95 million in 2016 and increasing to $204 million by 2020. This represents more than a doubling over the five-year period, with noticeable increments each year, particularly from 2017 to 2019.
- Depreciation and Amortization Trend
- Depreciation and amortization values have remained relatively stable across the same period, fluctuating slightly between $111 million and $121 million. There was a minor peak in 2018 with $121 million, followed by a decline to $111 million in 2019 and 2020.
- Segment Capital Expenditures to Depreciation Ratio
- The ratio of segment capital expenditures to depreciation has increased substantially, beginning at 0.82 in both 2016 and 2017 and rising sharply to 1.84 in 2020. This indicates that capital spending has grown at a faster pace than the depreciation expense, potentially reflecting expansion or investment in new assets beyond the rate of asset aging or usage reflected in depreciation.
- Overall Insights
- The upward trend in capital spending coupled with relatively stable depreciation suggests that the segment is likely investing heavily in new assets or upgrading existing infrastructure. The increasing capital expenditures relative to depreciation may imply an anticipation of future growth or capacity enhancement. The steadiness in depreciation suggests no significant asset write-downs or accelerated depreciation policies during this timeframe. These patterns indicate a strategic focus on expanding or modernizing the segment's asset base.
Net sales
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Personal Care | |||||
Consumer Tissue | |||||
K-C Professional | |||||
Corporate & Other | |||||
Total |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
- Personal Care Segment
- The net sales in the Personal Care segment showed a generally stable trend from 2016 to 2019, fluctuating slightly between approximately 9,037 and 9,108 million US dollars. In 2020, there was a notable increase to 9,339 million US dollars, marking the highest recorded value over the five-year period.
- Consumer Tissue Segment
- The Consumer Tissue segment experienced relatively stable sales during the period from 2016 through 2019, with values around 5,900 to 6,015 million US dollars. However, in 2020, this segment saw a significant rise to 6,718 million US dollars, indicating substantial growth compared to previous years.
- K-C Professional Segment
- The sales within the K-C Professional segment displayed moderate growth from 2016 through 2018, increasing from 3,150 million US dollars to a peak of 3,382 million US dollars. Following this peak, there was a decline in net sales in 2019 to 3,292 million, which further decreased in 2020 to 3,019 million US dollars, reflecting a downward trend in the later years.
- Corporate & Other Segment
- The Corporate & Other segment posted relatively low net sales values but demonstrated a consistent upward trend throughout the five years. Sales rose steadily from 39 million US dollars in 2016 to 64 million US dollars in 2020, exhibiting continuous incremental growth each year.
- Total Net Sales
- Total consolidated net sales showed a gradual upward trend over the examined period. From 18,202 million US dollars in 2016, total sales increased modestly each year, reaching 19,140 million US dollars in 2020. The largest incremental increase occurred between 2019 and 2020, largely influenced by gains in the Personal Care and Consumer Tissue segments.
- Summary of Trends
- Overall, the analysis reflects steady performance across most segments with pronounced growth in Consumer Tissue and Personal Care segments in the most recent year. Conversely, the K-C Professional segment faced a decline after reaching its peak in 2018. The Corporate & Other segment maintains consistent but minor contributions to total net sales. The cumulative effect of these segment trends results in a positive trajectory for total net sales over the five-year horizon.
Operating profit
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Personal Care | |||||
Consumer Tissue | |||||
K-C Professional | |||||
Corporate & Other | |||||
Other income and (expense), net | |||||
Total |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
The operating profit data presents various trends across the company’s reportable segments over the five-year period ending December 31, 2020. A detailed examination of each segment reveals distinct patterns in profitability.
- Personal Care
- The Personal Care segment demonstrates a generally stable operating profit trend with slight fluctuations. Starting at US$1,857 million in 2016, the profit increased modestly to US$1,907 million in 2017, then experienced a minor decline to US$1,833 million in 2018. The figures rebounded to US$1,904 million in 2019 and further increased to US$1,933 million in 2020, indicating steady performance and resilience in this segment.
- Consumer Tissue
- This segment shows notable volatility over the period. Beginning at US$1,117 million in 2016, operating profit decreased continuously to reach a low of US$875 million in 2018. However, a significant recovery occurred in the following years, with profit increasing to US$1,007 million in 2019 and sharply rising to US$1,448 million in 2020. This rebound suggests improved market conditions or successful operational initiatives late in the period.
- K-C Professional
- The K-C Professional segment reflects relative stability with slight variations, except for a decrease in the final year. From US$603 million in 2016, profit increased incrementally to US$634 million in 2018 and US$657 million in 2019. Nevertheless, a decline to US$528 million in 2020 interrupts this upward trend, potentially indicating challenges or market pressures during the last reported year.
- Corporate & Other
- Operating profit in the Corporate & Other segment remains negative throughout the timeframe, indicating a consistent operating loss in this category. The losses worsened significantly from US$-252 million in 2016 and US$-248 million in 2017 to a substantial negative margin of US$-1,112 million in 2018. Although losses decreased thereafter to US$-787 million in 2019 and US$-719 million in 2020, the segment continues to exert a negative effect on overall profitability.
- Other Income and (Expense), Net
- This category exhibits considerable variability and potential volatility in non-operating items. Starting with a minor loss of US$-8 million in 2016 and a larger loss of US$-27 million in 2017, it improved dramatically to near breakeven with a US$-1 million loss in 2018, followed by an unexpected gain of US$210 million in 2019. This positive fluctuation lessened to a gain of US$54 million in 2020, implying sporadic income or expense items influencing overall net results.
- Total Operating Profit
- Aggregate operating profit trends mirror the combined effects of segment fluctuations. Total profit was stable at just over US$3.3 billion in 2016 and 2017, but dropped sharply to US$2.23 billion in 2018, primarily driven by increased Corporate & Other losses and reduced Consumer Tissue profits. Recovery occurred in 2019 with profit rising to US$2.99 billion and further improving to US$3.24 billion in 2020, supported by gains in Personal Care and Consumer Tissue, despite decreases in K-C Professional and sustained losses in Corporate & Other.
Depreciation and amortization
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Personal Care | |||||
Consumer Tissue | |||||
K-C Professional | |||||
Corporate & Other | |||||
Total |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
The depreciation and amortization expenses across the reportable segments exhibit varying trends over the five-year period.
- Personal Care
- This segment shows a consistent increase in depreciation and amortization from 2016 to 2019, rising from 305 million US dollars to a peak of 430 million in 2019. However, in 2020, there is a notable decline to 347 million, indicating a reduction in expenses or asset base amortized within that year.
- Consumer Tissue
- The Consumer Tissue segment displays a gradual increase from 280 million in 2016 to 372 million in 2019. Similar to Personal Care, this segment experiences a decrease in 2020 to 334 million, though the magnitude of the drop is less pronounced compared to the previous segment.
- K-C Professional
- Depreciation and amortization amounts for the K-C Professional segment remain relatively stable throughout the period. The values decrease slightly from 116 million in 2016 to 111 million in 2019 and 2020, indicating minor fluctuations but overall consistent amortization expenses.
- Corporate & Other
- The Corporate & Other category maintains minimal depreciation and amortization expenses, fluctuating between 4 and 5 million over the years. This indicates low capital asset depreciation or amortization activity in this segment.
- Total
- The aggregate depreciation and amortization expenses increase steadily from 705 million in 2016 to 917 million in 2019, driven primarily by growth in the Personal Care and Consumer Tissue segments. In 2020, total expenses decline to 796 million, a decrease reflective of the reductions seen in the main operating segments, Personal Care and Consumer Tissue.
Overall, the data indicates growth in depreciation and amortization charges up to 2019, followed by a contraction in 2020. This pattern could reflect changes in asset investments, disposals, or revisions in amortization policies. The stability in K-C Professional and Corporate & Other segments suggests limited capital expenditure or asset base changes in those areas.
Capital spending
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Personal Care | |||||
Consumer Tissue | |||||
K-C Professional | |||||
Corporate & Other | |||||
Total |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
The capital spending data over the five-year period demonstrates varied growth trends across different segments. Overall, total capital expenditures increased consistently, rising from 771 million US dollars in 2016 to 1,217 million US dollars in 2020. This shows a significant overall increase of approximately 58% over the period, signaling intensified investment activities.
- Personal Care Segment
- This segment exhibits a steady upward trend in capital spending. Expenditures increased from 421 million US dollars in 2016 to 616 million in 2020. Notably, the increase was more pronounced from 2018 onwards, with a substantial jump between 2018 and 2019 (from 415 to 518 million) and continuing to 2020. This suggests a strategic focus on capital investment within this segment during the latter years.
- Consumer Tissue Segment
- Capital spending in this segment experienced fluctuations. It rose moderately from 250 million in 2016 to 299 million in 2018. However, there was a sharp increase to 489 million in 2019, followed by a decrease to 391 million in 2020. This pattern indicates that while investment surged significantly in 2019, there was a pullback the following year, possibly reflecting a reallocation of resources or completion of certain projects.
- K-C Professional Segment
- Capital expenditures in this segment more than doubled over the period, increasing from 95 million in 2016 to 204 million in 2020. The growth was particularly notable between 2017 and 2018, when spending jumped from 92 million to 157 million, followed by steady increases in subsequent years. This trend indicates a strong emphasis on expanding or upgrading professional product capabilities during the timeframe analyzed.
- Corporate & Other
- This segment maintained relatively low and stable capital spending, fluctuating minimally between 5 and 7 million throughout the five-year period. The stability suggests that capital investments in this category remained a minor component of the overall capital expenditure plan.
In summary, the data reflects strategic capital allocation decisions characterized by increased investment in Personal Care and K-C Professional segments, with Consumer Tissue showing more variable expenditure levels. Overall, capital spending intensified significantly, suggesting growth and expansion initiatives across the company’s core business areas during the five years ending in 2020.
Assets
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
---|---|---|---|---|---|
Personal Care | |||||
Consumer Tissue | |||||
K-C Professional | |||||
Corporate & Other | |||||
Total |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
The annual reportable segment assets data reveals distinct trends across different business segments over the five-year period ending December 31, 2020.
- Personal Care
- The Personal Care segment displays a generally upward trajectory. Assets increased from US$6,141 million in 2016 to US$8,486 million in 2020. The growth trend is steady, with a slight dip observed in 2018. The most notable increase occurred between 2019 and 2020, where assets rose by approximately 28%, indicating an accelerated expansion or investment in this segment during the latter part of the period.
- Consumer Tissue
- The Consumer Tissue segment exhibits relatively stable asset levels with minor fluctuations. Starting at US$4,761 million in 2016, the segment experienced a slight decline in 2018 to US$4,738 million, followed by a gradual increase reaching US$5,227 million in 2020. The overall growth across the five years is modest, suggesting a steady but slow expansion or maintenance of asset base within this segment.
- K-C Professional
- The K-C Professional segment shows consistent growth throughout the period. Assets increased from US$2,151 million in 2016 to US$2,551 million in 2020. The increase is gradual year-over-year, reflecting sustained investment or asset accumulation without any significant fluctuations, indicative of stable development in this segment.
- Corporate & Other
- The Corporate & Other segment exhibits a downward trend in asset values. Starting at US$1,549 million in 2016, assets steadily decreased to around US$1,259 million by 2020. This decline suggests possible asset divestitures, cost control measures, or reduced allocation to corporate-level or miscellaneous assets during the period.
- Total Assets
- Total reportable segment assets experienced fluctuations but ultimately increased over the five years. From US$14,602 million in 2016, the total assets saw a minor dip in 2018 to US$14,518 million but recovered thereafter, reaching US$17,523 million in 2020. The net increase indicates an overall expansion in asset base across the company's reportable segments, with the sharpest growth occurring in the final year of the period.